UniSA's weekly injectable gel delivers levodopa and carbidopa, potentially transforming Parkinson's care for 8.5M people by simplifying treatment and reducing side effects.

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Lack of knowledge about common diseases that pets experience can be dangerous. If you do not know the symptoms to look out ...

A little weight gain during the menopause is normal, but when it happens to a generation who came of age in the skinny-chic ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Everyday wear and tear can take a significant toll on your teeth as you get older, so prioritising your oral health routine ...

Remarkably, the benefits of GLP-1RA and SGLT2i are independent of type 2 diabetes status or baseline renal function. The critical role of these drug classes in managing high cardiovascular risk ...

Your blood sugar can affect more than your propensity for diabetes. In fact, high blood sugar may be causing you to lose out on some of life’s most intimate moments.

NHS Commercial guidance on applying social value in the procurement of NHS goods and services In 2020, the NHS became the ...

Gemma Collins says she was shocked by how her face changed after losing two stone on Mounjaro. Experts warn of a side effect now dubbed 'Ozempic face'.